Former senator joins Blink Health’s board
Blink Health, an app that offers low-cost prescription drug prices, announced that former U.S. senator and New Hampshire attorney general Kelly Ayotte is joining its board of directors.
Ayotte, who has been a senior advisor to Blink since 2017, will take an even more active role supporting the company’s mission of bringing transparency and affordability to the prescription drug industry.
Blink said Ayotte will be a strong advocate for Blink’s mission of increasing accessibility and reducing prescription drug costs for American families. “She will work with the company’s other experienced board members — including executive chairman Bill Doyle, co-founders Geoffrey and Matthew Chaiken, and Tom Tryforos — to support Blink’s continued growth and help expand the company’s efforts to provide the lowest prices on prescription medications,” the company said.
“Kelly understands that Blink threatens industry incumbents who have tried to protect their profits by keeping drug prices high,” Blink Health CEO Geoffrey Chaiken said. "We’re honored to have her join us and confident we will benefit from her expertise and insights.”
“I’ve always been a fierce advocate for improving the U.S. healthcare system and lowering patient costs, so I was drawn to Blink as a new private market solution to the drug price crisis,” Ayotte said. “Blink brings transparency and a patient-centric approach to the prescription supply chain, providing policymakers with an effective model for needed change.”
Ayotte, who has been a senior advisor to Blink since 2017, will take an even more active role supporting the company’s mission of bringing transparency and affordability to the prescription drug industry.
Blink said Ayotte will be a strong advocate for Blink’s mission of increasing accessibility and reducing prescription drug costs for American families. “She will work with the company’s other experienced board members — including executive chairman Bill Doyle, co-founders Geoffrey and Matthew Chaiken, and Tom Tryforos — to support Blink’s continued growth and help expand the company’s efforts to provide the lowest prices on prescription medications,” the company said.
“Kelly understands that Blink threatens industry incumbents who have tried to protect their profits by keeping drug prices high,” Blink Health CEO Geoffrey Chaiken said. "We’re honored to have her join us and confident we will benefit from her expertise and insights.”
“I’ve always been a fierce advocate for improving the U.S. healthcare system and lowering patient costs, so I was drawn to Blink as a new private market solution to the drug price crisis,” Ayotte said. “Blink brings transparency and a patient-centric approach to the prescription supply chain, providing policymakers with an effective model for needed change.”